Aleksey Krylov is a strategic Chief Financial Officer to life sciences and medical technology companies with a background in venture investing and M&A.
TRC is 2,400 technical professionals and support personnel at more than 70 offices throughout the U.S. Our clients depend on TRC’s multidisciplinary teams to design solutions to their toughest business challenges.